Pra Health Sciences Inc (PRAH) Return on Equity ROE from the first quarter 2021 to first quarter 2020 and annually, average high and low, overall ranking from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pra Health Sciences Inc   (NASDAQ: PRAH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Pra Health Sciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Pra Health Sciences Inc in the first quarter 2021?
Pra Health Sciences Inc achieved a return on average equity (ROE) of 15.43 % in its first quarter 2021, this is above PRAH's average return on equity of 13.9%.
Pra Health Sciences Inc shareholder's equity over the 12 months ending in its first quarter 2021 are valued at $1,382 million

ROE fell compared to the fourth quarter 2020, despite the net income growth of 11.09% from the fourth quarter 2020.

Within the Medical Laboratories industry 9 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2020 from 742 to 916.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Equity Change 40.55 % 35.71 % 39.98 % 0.32 % -
Y / Y Net Income Change 40.04 % -31.48 % 9.93 % -66.21 % -8.13 %
Net Income (TTM) in Millions 213 197 221 212 240
Return On Equity (TTM) 15.43 % 15.52 % 18.81 % 19.7 % 22.24 %
PRAH's Total Ranking # 916 # 742 # 494 # 0 # 440
Equity (TTM) in Millions 1,557 1,479 1,325 1,167 1,107
Seq. Equity Change 5.23 % 11.61 % 13.52 % 5.42 % 1.6 %
Seq. Net Income Change 11.09 % -43.83 % 557.72 % -65.88 % -45.64 %

Back to PRAH Management Effectiveness >> PRAH's 5 Years Annual ROE >> Compare PRAH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 10
Sector # 114
Overall # 916

Return On Equity Statistics
High Average Low
22.53 %
13.9 %
4.49 %
(Dec 31 2019)   (Sep 30 2015)





PRAH Annual Return On Equity (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Equity in Millions 1,479 1,090 1,051 936 729
Y / Y Equity Change 35.71 % 3.67 % 12.27 % 28.42 % 3.78 %
Net Income in Millions 197 243 154 88 68
Y / Y Net Income Change -18.95 % 57.4 % 76.2 % 28.58 % -16.62 %
Return On Equity 13.32 % 22.3 % 14.69 % 9.36 % 9.35 %

Back to PRAH Management Effectiveness >> PRAH's 5 Years Annual ROE >> Compare PRAH ROE to its Competitors




Annual Roe Comment
In 2020 ROE decreased compared to the previous year to 13.32 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PRAH's' Return on Equity at Yahoo Finance
PRAH's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PRAH's Competitors
Subscribers only: Roe for Pra Health Sciences Inc 's Suppliers
Subscribers only: Return On Equity for PRAH's Customers




Companies with similar Return On Equity at Mar 31 2021, within Healthcare Sector ROE
Harrow Inc   40.92 %
Neurocrine Biosciences Inc   40.53 %
Chemed Corporation  38.91 %
Progyny Inc   38.86 %
Pro dex Inc   38.65 %
Elite Pharmaceuticals Inc   38.25 %
Regeneron Pharmaceuticals Inc   37.96 %
Viemed Healthcare Inc   37.21 %
Abbvie Inc   36.35 %
Dexcom Inc   35.06 %
Lifevantage Corp  34.67 %
Vertex Pharmaceuticals Inc  33.16 %
Select Medical Holdings Corp  32.94 %
Meridian Bioscience Inc   32.57 %
Revvity Inc  30.81 %
Labcorp Holdings Inc   30.24 %
Voyager Therapeutics Inc   29.50 %
Oramed Pharmaceuticals Inc  29.17 %
Quest Diagnostics Inc  29.05 %
Emergent Biosolutions Inc   28.41 %
Vaso Corporation  28.36 %
Biogen Inc   28.33 %
Blueprint Medicines Corporation  27.26 %
Lakeland Industries Inc   26.89 %
Amedisys Inc  26.42 %
Pacira Biosciences inc   26.34 %
Biodelivery Sciences International Inc   26.13 %
Merck and Co Inc   25.76 %
Collegium Pharmaceutical Inc   24.52 %
Encision Inc   24.36 %

Date modified: 2026-09-12T06:15:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.